Companies: 10,795·Total market cap: $144.5T
Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc.

AVIRNASDAQHealthcare● Active
$4.35
+$0.10(+2.34%)
Market Cap$348077867
P/E Ratio
52W High$6.45
52W Low$2.78
Overview

Atea Pharmaceuticals, Inc.(AVIR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · AVIR · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.35B
Cost of Revenue$0.00B$0.08B$0.07B$0.06B$0.17B
Gross Profit$0.00B($0.08B)($0.07B)($0.06B)$0.18B
Gross Margin %(computed)52.41%
Operating Expenses
R&D Expenses$0.15B$0.15B$0.13B$0.09B$0.17B
G&A Expenses$0.03B$0.05B$0.05B$0.05B$0.05B
Total Operating Expenses$0.18B$0.11B$0.09B$0.07B$0.05B
Operating Income($0.18B)($0.19B)($0.16B)($0.13B)$0.14B
Operating Margin %(computed)39.38%
Interest Income$0.02B$0.03B$0.03B$0.01B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.01B$0.00B
Income Before Tax($0.16B)($0.17B)($0.13B)($0.12B)$0.14B
Income Tax Expense($0.01B)$0.00B$0.00B($0.00B)$0.02B
Net Income($0.16B)($0.17B)($0.14B)($0.12B)$0.12B
Net Margin %(computed)34.49%
Per Share & EBITDA
EPS (Basic)$-1.94$-2.00$-1.63$-1.39$1.46
Wtd Avg Shares0.08B0.08B0.08B0.08B0.08B
EBITDA($0.18B)($0.13B)($0.12B)($0.11B)$0.14B
EBITDA Margin %(computed)39.39%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Atea Pharmaceuticals, Inc.

关于Atea Pharmaceuticals, Inc.(AVIR)损益表

Atea Pharmaceuticals, Inc.(AVIR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,AVIR实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.16B)(净利率—)。

常见问题

AVIR · 4 问

Atea Pharmaceuticals, Inc.(AVIR)2025财年营收为$0.00B,同比down—%。

AVIR revenueAVIR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08